The disclosure features systems and methods for measuring and diagnosing target constituents bound to labeling particles in a sample. The systems include a radiation source, a sample holder, a detector configured to obtain one or more diffraction patterns of the sample each including information corresponding to optical properties of sample constituents, and an electronic processor configured to, for each of the one or more diffraction patterns: (a) analyze the diffraction pattern to obtain amplitude information and phase information corresponding to the sample constituents; (b) identify one or more particle-bound target sample constituents based on at least one of the amplitude information and the phase information; and (c) determine an amount of at least one of the particle-bound target sample constituents in the sample based on at least one of the amplitude information and the phase information.

The present invention relates to the field of microfluidics and in particular to devices and methods for sorting objects in microfluidic channels. These devices and methods allow for fast and robust sorting in two-way and multi-way setups. They also enable sorting over extended periods of time.

The disclosure provides a method of detecting heterogeneity of disease in a cancer patient comprising (a) performing a direct analysis comprising immunofluorescent staining and morphological characteristization of nucleated cells in a blood sample obtained from the patient to identify and enumerate circulating tumor cells (CTC); (b) isolating the CTCs from the sample; (c) individually characterizing genomic parameters to generate a genomic profile for each of the CTCs, and (d) determining heterogeneity of disease in the cancer patient based on the profile. In some embodiments, the cancer is prostate cancer. In some embodiments, the prostate cancer is hormone refractory.

The disclosure provides a method of detecting heterogeneity of disease in a cancer patient comprising (a) performing a direct analysis comprising immunofluorescent staining and morphological characteristization of nucleated cells in a blood sample obtained from the patient to identify and enumerate circulating tumor cells (CTC); (b) isolating the CTCs from the sample; (c) individually characterizing genomic parameters to generate a genomic profile for each of the CTCs, and (d) determining heterogeneity of disease in the cancer patient based on the profile. In some embodiments, the cancer is prostate cancer. In some embodiments, the prostate cancer is hormone refractory.

The present disclosure provides a method and a system therefore for processing wafer. The method includes: monitoring a distribution of particles in a chamber while processing the wafer; determining at least one parameter according to the distribution of the particles for configuring at least one device of the chamber; configuring the at least one device of the chamber according to the at least one parameter; and processing another wafer based on a recipe after configuring the at least one device of the chamber.

A method for optically detecting biomarkers in a biosensor is disclosed, wherein the optical detection obtains spatially and spectrally resolved optical signals from a sample on a biosensor, and one or more of these spatially and spectrally resolved optical signals can be analyzed in parallel with image acquisition. The image analysis comprises reading data of the acquired images, correcting them to reduce inhomogeneities and noise, localizing particles in the images, characterizing each particle individually to obtain its position and characterization parameters, and classifying the particles based on their characterization parameters. Using the number of particles per class for all the acquired images of the sample, a statistical value is calculated per sample and each statistical value is correlated with an indication of the presence of a biomarker in the sample.

Embodiments of the present technology include a method for testing a blood sample for sepsis. The method may include receiving a blood sample from an individual. The method may also include executing an instruction to analyze the blood sample for sepsis. In addition, the method may include measuring values of a set of characteristics in the blood sample. The set of characteristics being determined prior to measuring the values. The method may further include analyzing the values of the set of characteristics to produce a representation of a suspicion of sepsis. In addition, the method may include displaying the representation. Embodiments also include systems for testing blood sample for sepsis.

Determination of transport phenomena properties in porous media is one major objective of core analysis studies in petrophysics, reservoir engineering, and groundwater hydrology. Porosity measurement may be considered as a key factor to identify the hydraulic performance of a low permeable porous medium (e.g. rock or concrete). Additionally, the rate of absorption under pressure depends on the permeability, which is related to the connectivity between the existing pores within the porous structure. An alternative Gas Expansion Induced Water Intrusion Porosimetry (GEIWIP) method and apparatus is useful to measure the total porosity and pore size distribution, using a gas/water intrusion apparatus for water tight materials.

Determination of transport phenomena properties in porous media is one major objective of core analysis studies in petrophysics, reservoir engineering, and groundwater hydrology. Porosity measurement may be considered as a key factor to identify the hydraulic performance of a low permeable porous medium (e.g. rock or concrete). Additionally, the rate of absorption under pressure depends on the permeability, which is related to the connectivity between the existing pores within the porous structure. An alternative Gas Expansion Induced Water Intrusion Porosimetry (GEIWIP) method and apparatus is useful to measure the total porosity and pore size distribution, using a gas/water intrusion apparatus for water tight materials.

An apparatus for detecting fine dust and microorganisms includes: a sample chamber body including a sample chamber, a light-incidence port through which incident light is incident, and a first light exit port and a second light exit port for emitting the incident light irradiated to the measurement sample; a light-transmitting unit; a first light-receiving unit which separately transmits, via a first path and a second path, exiting light emitted from the first light exit port, detects scattering light from the exiting light transmitted via the first path, and detects fluorescence light of the exiting light transmitted via the second path; a diffused reflection reduction unit provided between the first light exit port and the first light-receiving unit; and a second light-receiving unit which condenses in a Mie-scattering manner and transmits exiting light emitted from the second light exit port and detects fluorescence light of the exiting light.